• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WU Yong, CHEN Dengjun, WANG Xiao, SUN Hongzhang, HUO Meirong. Preparation，physicochemical properties and pharmacokinetics in rats of CHMFL-KIT-110 solid dispersions[J]. Journal of China Pharmaceutical University, 2020, 51(6): 688-695. DOI: 10.11665/j.issn.1000-5048.20200607
Citation: WU Yong, CHEN Dengjun, WANG Xiao, SUN Hongzhang, HUO Meirong. Preparation，physicochemical properties and pharmacokinetics in rats of CHMFL-KIT-110 solid dispersions[J]. Journal of China Pharmaceutical University, 2020, 51(6): 688-695. DOI: 10.11665/j.issn.1000-5048.20200607
shu

Preparation，physicochemical properties and pharmacokinetics in rats of CHMFL-KIT-110 solid dispersions

Funds: This work was supported by the National Science and Technology Major Project-Major New Drug Creation (No.2017ZX09101001)
More Information
  • Received Date: May 11, 2020
  • Revised Date: October 08, 2020
    Graphical Abstract
    • Abstract
  • Solid dispersions of the insoluble compound CHMFL-KIT-110 were prepared by solvent method with polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (Soluplus),Poloxamer 407,PEG 6000,Copovidone (Kollidon VA64) as carriers and SLS,Tween 80,Cremophor RH40 as solubilizers. The optimal formulation was screened and obtained with dynamic solubilities and supersaturation performances as indexes. The final product was characterized by Fourier transform infrared (FT-IR),differential thermal analysis (DTA) and X-ray powder diffraction (XRPD). The stability and pharmacokinetic behavior in rats were also investigated. Results suggested that when the weight ratio of CHMFL-KIT-110/Soluplus/SLS was 1∶4∶0.5,dynamic solubility of the solid dispersions was significantly improved with no recrystallization. In the accelerated condition (40 °C,75% RH) for 30 days,CHMFL-KIT-110 in the solid dispersions was still amorphous with no crystal observed. The results of pharmacokinetics in rats showed that the cmax and AUC0→t of CHMFL-KIT-110 solid dispersions were 373.1 times and 358.7 times higher than those of free drugs,respectively. These results help to understand the formulation development and clinical practice of CHMFL-KIT-110.
    • FullText(HTML)
    • References (8)
  • [1]
    . J Med Chem，2016，59（8）：3964?3979.
    [2]
    Lee TW，Boersen NA，Hui HW，et al. Delivery of poorly soluble compounds by amorphous solid dispersions［J］. Curr Pharm Des，2014，20（3）：303?324.
    [3]
    Linn M，Collnot EM，L，Djuric D，et al. Soluplus? as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo［J］. Eur J Pharm Sci，2012，45（3）：336?343.
    [4]
    Vasconcelos T，Sarmento B，Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs［J］. Drug Discov Today，2007，12（23-24）：1068?1075.
    [5]
    Lavra ZM，Santana DP，Ré MI. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus?［J］. Drug Dev Ind Pharm，2017，43（1）：42?54.
    [6]
    Meng F，Gala U，Chauhan H. Classification of solid dispersions：correlation to （i） stability and solubility （ii） preparation and characterization techniques［J］. Drug Dev Ind Pharm，2015，41（9）：1401?1415.
    [7]
    Xia DN，Yu HZ，Tao JS，et al. Supersaturated polymeric micelles for oral cyclosporine A delivery：the role of Soluplus-sodium dodecyl sulfate complex［J］. Colloids Surf B Biointerfaces，2016，141：301?310.
    [8]
    Chen，JL，Chen YQ，Huang WC，et al. Bottom-up and top-down approaches to explore sodium dodecyl sulfate and soluplus on the crystallization inhibition and dissolution of felodipine extrudates［J］. J Pharm Sci，2018，107（9）：2366?2376.
    • Related Articles

  • Related Articles

    [1]CHEN Xin, YANG Qian, YOU Qidong, GUO Xiaoke. Advances of inhibitors targeting MLL1-WDR5 protein-protein interaction[J]. Journal of China Pharmaceutical University, 2022, 53(2): 125-136. DOI: 10.11665/j.issn.1000-5048.20220201
    [2]ZHANG Yuxin, DING Ming, LIU Jun. Research progress of proximity labeling technology based on biotin ligase in proteomics[J]. Journal of China Pharmaceutical University, 2022, 53(1): 18-24. DOI: 10.11665/j.issn.1000-5048.20220103
    [3]MO Xiaofei, XU Xiaoli, WANG Yalou, YOU Qidong. Advances in the HIF-1α/p300 protein-protein interaction inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(5): 515-522. DOI: 10.11665/j.issn.1000-5048.20170502
    [4]LIU Fang, SUN Haopeng, YOU Qidong. Advances in small-molecule inhibitors targeting Hsp90-Cdc37 protein-protein interaction[J]. Journal of China Pharmaceutical University, 2015, 46(3): 272-278. DOI: 10.11665/j.issn.1000-5048.20150303
    [5]The Effect of Inducer on Enzyme Activity of Dihydropyri midinase[J]. Journal of China Pharmaceutical University, 1999, (3): 60-63.
    [6]Purification and Characterization of Potent Fibrinolytic Enzyme from Earthworm[J]. Journal of China Pharmaceutical University, 1997, (6): 48-51.
    [7]Pharmacokinetic Studies of Nevin Fibrinolytic Enzyme[J]. Journal of China Pharmaceutical University, 1997, (2): 107-110.
    [8]Effect of Astragalus on Fluidity of Lipid Regions and Conformation of Protein of Human Erythrocyte Membranes[J]. Journal of China Pharmaceutical University, 1994, (4): 49-52.
    [9]Interaction of Four Berbamine Derivatives with Erythrocyte Membrane Ca~(2 )-Mg~(2 )-ATPase[J]. Journal of China Pharmaceutical University, 1993, (5): 304-307.
    [10]Wu Wutong. Advances in enzyme drugs[J]. Journal of China Pharmaceutical University, 1982, (3): 59-64.

  • Cited by

    Periodical cited type(3)

    1. 李锦华，祁萍，乔慧. ALK-TKI耐药后获得性RET融合晚期非小细胞肺癌1例报道并文献复习. 肿瘤防治研究. 2024(08): 703-706 .
    2. 王瑞峰，赵相欣，孙印，秦桥花，赵冬梅. 降解FAK的PROTAC分子的设计合成及生物活性研究. 中国药物化学杂志. 2023(07): 481-489 .
    3. 王梓灵，郭瑜婕，朱芸芸，陈乐，吴婷，刘大会，黄必胜，杜鸿志. 金花茶有效部位抑制表皮生长因子受体(EGFR)抗非小细胞肺癌的作用机制研究. 中国中药杂志. 2021(20): 5362-5371 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by(5)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365379

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return